Skip to content

NEUROCRINE BIOSCIENCES INC

NBIX

CIK 0000914475

← back to feed
Revenue (TTM)
$2.87B
+21.4% YoY Q1 Apr 2026
Net Income (TTM)
$522.8M
+40.2% YoY Q1 Apr 2026
EPS Diluted (TTM)
$5.09
+41.9% YoY Q1 Apr 2026
Gross Margin
98.3%
Q1 Apr 2026
Operating Margin
21.0%
Q1 Apr 2026
Net Margin
18.2%
Q1 Apr 2026
Free Cash Flow (TTM)
$176.2M
Q1 Apr 2026
Cash
$266.5M
Q1 Apr 2026
Total Debt
—
Q1 Apr 2026
Shares Outstanding
100.55M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings